申请人:Bristol-Myers Squibb Company
公开号:US20130178462A1
公开(公告)日:2013-07-11
The present disclosure provides a series of compounds of the formula (I)
which modulate β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
本公开提供了一系列化合物的公式(I),这些化合物可以调节β-淀粉样肽(β-AP)的产生,并且在治疗阿尔茨海默病和其他受β-淀粉样肽(β-AP)产生影响的疾病方面是有用的。